Arkolith/Insider Trading/TCRX/Form 4

Nichols Weston

10% OwnerTScan Therapeutics, Inc. (TCRX) · full profile →Form 4 · filed Dec 16, 2024
Net Buying
Open-Market Buys
$386K
Open-Market Sells
$0
Net Open-Market Flow
$386K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 13, 2024Buy(P)100K$2.90$290K5.4M
Dec 12, 2024Buy(P)32K$3.01$96K5.3M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000902664-24-006934) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML